If your practice is any good, the letters and calls will come — consolidators employ full-time outreach teams, and every independent owner eventually hears a number. Whether you’d never sell, might someday, or are quietly curious, the same rule applies: understand what these offers actually contain before one is sitting on your desk with a deadline attached. Here’s the anatomy.
The headline number isn’t the deal
The era of clean all-cash closings is over: consolidator offers now combine cash at closing with equity, promissory notes, and/or earnout payments — a typical PE-backed structure pays 70–85% at closing with 15–30% contingent on hitting benchmarks over 12–24 months. Each component deserves its own scrutiny:
- Earnouts — contingent payments tied to post-sale performance milestones. The traps are structural: targets can be hard to achieve, payment waits until the earnout period expires even if you exceed milestones early, and — the subtle one — you’ll be chasing those targets inside a practice you no longer control (their pricing, their staffing decisions, their software migrations). Targets are shifting from EBITDA to revenue bases, which at least removes expense games from the math. Value an earnout at a healthy discount to face.
- Equity rollover — a slice of your proceeds converted into the consolidator’s (or its parent fund’s) equity, pitched as “a second bite of the apple.” Sometimes it is; it’s also illiquid, minority, and dependent on the fund’s exit. Diligence their business before accepting their paper as payment.
- Holdbacks and retention bonuses — portions paid later, contingent on staying or on representations holding true.
The part that changes your life: the employment agreement
Most consolidators require the seller to stay on — typically 2–3+ years — and the employment agreement’s compensation, role, and restrictions deserve scrutiny equal to the purchase agreement, along with the noncompete’s duration and radius, and the retention packages offered to your associates. The honest self-assessment most sellers skip: you will go from owner to employee in the same building, practicing under protocols, pricing, and staffing models you don’t set. Some sellers thrive; many count the days. Price your autonomy honestly — it’s the thing you’re actually selling.
Evaluating without being rushed
- Know your number first. A current independent valuation (valuation guide) turns “wow, that’s a lot” into “that’s 7.1× — the market band is 6–12×.” Unsolicited offers anchor low more often than owners realize.
- Never negotiate one buyer. Corporate vs. private buyers differ structurally, and consolidators compete with each other; a broker-run or advisor-run process with multiple bidders routinely moves both price and terms. The four sale paths — corporate, private DVM, associate buy-in, hybrid — should all be priced before any is chosen (exit-planning guide).
- Model the after-tax, risk-adjusted, whole-deal value: cash at close (real) + earnout (discounted) + equity (speculative) + employment comp (salary for years of your life) − taxes (deal structure moves this hugely — asset vs. equity sale treatment is its own negotiation). Your CPA and a deal-experienced attorney are not optional at LOI stage.
- Diligence the buyer: what happened to the last five practices they bought — staff retention, medicine standards, the sellers’ earnout outcomes? Call those sellers. Consolidators diligence you for months; reciprocate.
- Protect the team in writing — associate retention terms, staff treatment, and what happens to the culture you built are negotiable while you have leverage and unfixable after closing. And if the answer is no — a good offer you decline is free information: it tells you what the market pays for what you’ve built, and the drivers list from the valuation guide tells you how to make the next unsolicited letter bigger. Independence and sellability are, conveniently, built by the same habits. This article is general information, not legal, tax, or financial advice. Engage deal-experienced professionals before responding to any offer. Sources: Mahan Law — Selling to a Corporate Consolidator · Wicklow — Selling to Corporate Entities · Ackerman Group — How Earnouts & Contingent Notes Work · Mandelbaum Barrett — Step-by-Step Guide to Selling to a Consolidator · Simmons — Four Methods to Sell Your Practice · RightFit Capital — Taxes, Deal Structure & Earnouts Explained